Marta Schilling, BSc
Senior Director, Manufacturing Operations & Process Development (West Coast)
mschilling@progenitorcelltherapy.com

Joining Progenitor Cell Therapy as Director Manufacturing Operations (West Coast) in 2007, Ms. Schilling was promoted to Senior Director, Manufacturing Operations and Process Development (West Coast) in 2008.

Ms. Schilling is a cellular therapy specialist with over 20 years of experience spanning corporate research and development, clinical trials, customer training and support and cGMP cell therapy manufacturing. Prior to joining PCT, Ms. Schilling was the Associate Director of the Cell Processing Laboratory at IDM Pharma in Irvine, California where she was instrumental in setting up the cGMP manufacturing facility and systems as well as scientifically involved in process improvements for producing autologous dendritic cell vaccines for Phase I/II clinical trials.

Previously she was at Baxter Healthcare and later Nexell Therapeutics where she was involved in the research, development and customer support of the Isolex® CD34 Cell Selection System and the CytoMate® Cell Washer Device. Her responsibilities included supporting customers throughout the United States, Canada, Europe, Singapore, Japan and Australia. Over the course of her long career at Baxter and Nexell, Ms. Schilling has personally trained and supported many of the pioneers in cell therapy and brings with her a large network of peers and vast understanding of the technical issues in this evolving field.

Ms. Schilling was awarded her Bachelor of Science degree in Medical Technology, specializing in Hematology, from the University of Vermont. She has presented her work in numerous peer-reviewed scientific journals and at international meetings.